227 related articles for article (PubMed ID: 20562188)
21. 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.
Munger KL; Hongell K; Åivo J; Soilu-Hänninen M; Surcel HM; Ascherio A
Neurology; 2017 Oct; 89(15):1578-1583. PubMed ID: 28904091
[TBL] [Abstract][Full Text] [Related]
22. The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases.
Schleicher RL; Sternberg MR; Lacher DA; Sempos CT; Looker AC; Durazo-Arvizu RA; Yetley EA; Chaudhary-Webb M; Maw KL; Pfeiffer CM; Johnson CL
Am J Clin Nutr; 2016 Aug; 104(2):454-61. PubMed ID: 27385610
[TBL] [Abstract][Full Text] [Related]
23. National Estimates of Serum Total 25-Hydroxyvitamin D and Metabolite Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry in the US Population during 2007-2010.
Schleicher RL; Sternberg MR; Looker AC; Yetley EA; Lacher DA; Sempos CT; Taylor CL; Durazo-Arvizu RA; Maw KL; Chaudhary-Webb M; Johnson CL; Pfeiffer CM
J Nutr; 2016 May; 146(5):1051-61. PubMed ID: 27052537
[TBL] [Abstract][Full Text] [Related]
24. Vitamin D and pancreatic cancer risk - no U-shaped curve.
Baggerly LL; Garland CF
Anticancer Res; 2012 Mar; 32(3):981-4. PubMed ID: 22399620
[TBL] [Abstract][Full Text] [Related]
25. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study.
de Boer IH; Levin G; Robinson-Cohen C; Biggs ML; Hoofnagle AN; Siscovick DS; Kestenbaum B
Ann Intern Med; 2012 May; 156(9):627-34. PubMed ID: 22547472
[TBL] [Abstract][Full Text] [Related]
26. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers.
Lim U; Freedman DM; Hollis BW; Horst RL; Purdue MP; Chatterjee N; Weinstein SJ; Morton LM; Schatzkin A; Virtamo J; Linet MS; Hartge P; Albanes D
Int J Cancer; 2009 Feb; 124(4):979-86. PubMed ID: 19035445
[TBL] [Abstract][Full Text] [Related]
27. Serum 25-hydroxyvitamin D and the risk of ovarian cancer.
Toriola AT; Surcel HM; Agborsangaya C; Grankvist K; Tuohimaa P; Toniolo P; Lukanova A; Pukkala E; Lehtinen M
Eur J Cancer; 2010 Jan; 46(2):364-9. PubMed ID: 19713101
[TBL] [Abstract][Full Text] [Related]
28. Potential determinants of vitamin D in Finnish adults: a cross-sectional study from the Northern Finland birth cohort 1966.
Palaniswamy S; Hyppönen E; Williams DM; Jokelainen J; Lowry E; Keinänen-Kiukaanniemi S; Herzig KH; Järvelin MR; Sebert S
BMJ Open; 2017 Mar; 7(3):e013161. PubMed ID: 28264828
[TBL] [Abstract][Full Text] [Related]
29. WCRF-AICR continuous update project: Systematic literature review of prospective studies on circulating 25-hydroxyvitamin D and kidney cancer risk.
Darling AL; Abar L; Norat T
J Steroid Biochem Mol Biol; 2016 Nov; 164():85-89. PubMed ID: 26454157
[TBL] [Abstract][Full Text] [Related]
30. Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis.
Hiraki LT; Arkema EV; Cui J; Malspeis S; Costenbader KH; Karlson EW
Rheumatology (Oxford); 2014 Dec; 53(12):2243-8. PubMed ID: 25065001
[TBL] [Abstract][Full Text] [Related]
31. Remarkable improvement in serum 25-hydroxyvitamin levels among hip fracture patients over a 12-year period: a prospective study in South-eastern Finland.
Nurmi-Lüthje I; Tiihonen R; Paattiniemi EL; Naboulsi H; Pigg S; Sarkkinen H; Kaukonen JP; Toivanen A; Salmio K; Kataja M; Lüthje P
Osteoporos Int; 2018 Apr; 29(4):837-845. PubMed ID: 29260288
[TBL] [Abstract][Full Text] [Related]
32. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men.
Laaksi I; Ruohola JP; Tuohimaa P; Auvinen A; Haataja R; Pihlajamäki H; Ylikomi T
Am J Clin Nutr; 2007 Sep; 86(3):714-7. PubMed ID: 17823437
[TBL] [Abstract][Full Text] [Related]
33. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data.
Jääskeläinen T; Itkonen ST; Lundqvist A; Erkkola M; Koskela T; Lakkala K; Dowling KG; Hull GL; Kröger H; Karppinen J; Kyllönen E; Härkänen T; Cashman KD; Männistö S; Lamberg-Allardt C
Am J Clin Nutr; 2017 Jun; 105(6):1512-1520. PubMed ID: 28490516
[No Abstract] [Full Text] [Related]
34. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.
Ordóñez-Mena JM; Schöttker B; Fedirko V; Jenab M; Olsen A; Halkjær J; Kampman E; de Groot L; Jansen E; Bueno-de-Mesquita HB; Peeters PH; Siganos G; Wilsgaard T; Perna L; Holleczek B; Pettersson-Kymmer U; Orfanos P; Trichopoulou A; Boffetta P; Brenner H
Eur J Epidemiol; 2016 Mar; 31(3):311-23. PubMed ID: 25977096
[TBL] [Abstract][Full Text] [Related]
35. Plasma 25-hydroxyvitamin D concentration and lymphoma risk: results of the European Prospective Investigation into Cancer and Nutrition.
Łuczyńska A; Kaaks R; Rohrmann S; Becker S; Linseisen J; Buijsse B; Overvad K; Trichopoulou A; Valanou E; Barmpitsioti A; Masala G; Agnoli C; Tumino R; Panico S; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Vermeulen R; Weiderpass E; Brustad M; Skeie G; González CA; Jakszyn P; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Melin B; Johansson AS; Almquist M; Malm J; Khaw KT; Wareham N; Travis RC; Fedirko V; Romieu I; Jenab M; Gallo V; Riboli E; Vineis P; Nieters A
Am J Clin Nutr; 2013 Sep; 98(3):827-38. PubMed ID: 23885049
[TBL] [Abstract][Full Text] [Related]
36. Plasma 25-hydroxyvitamin D concentrations and risk of incident cancer in adults with hypertension: A nested case-control study.
Lin T; Song Y; Zhang X; Guo H; Liu L; Zhou Z; Wang B; Tang G; Liu C; Yang Y; Ling W; Yuan Z; Li J; Zhang Y; Huo Y; Wang X; Zhang H; Qin X; Xu X
Clin Nutr; 2019 Oct; 38(5):2381-2388. PubMed ID: 30473442
[TBL] [Abstract][Full Text] [Related]
37. A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.
Finnes TE; Lofthus CM; Meyer HE; Søgaard AJ; Tell GS; Apalset EM; Gjesdal C; Grimnes G; Schei B; Blomhoff R; Samuelsen SO; Holvik K
Osteoporos Int; 2016 Apr; 27(4):1645-1652. PubMed ID: 26630974
[TBL] [Abstract][Full Text] [Related]
38. Casting light on 25-hydroxyvitamin D deficiency in ovarian cancer: a study from the NHANES.
Bakhru A; Mallinger JB; Buckanovich RJ; Griggs JJ
Gynecol Oncol; 2010 Nov; 119(2):314-8. PubMed ID: 20684976
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL).
Molica S; Digiesi G; Antenucci A; Levato L; Mirabelli R; Molica M; Gentile M; Giannarelli D; Sperduti I; Morabito F; Conti L
Leuk Res; 2012 Apr; 36(4):443-7. PubMed ID: 22047708
[TBL] [Abstract][Full Text] [Related]
40. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance).
Van Loon K; Owzar K; Jiang C; Kindler HL; Mulcahy MF; Niedzwiecki D; O'Reilly EM; Fuchs C; Innocenti F; Venook AP;
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25099612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]